Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018382 |
---|---|
Receipt number | R000021286 |
Scientific Title | Phase I study of neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel for patients with borderline resectable pancreatic cancer |
Date of disclosure of the study information | 2015/07/22 |
Last modified on | 2017/07/01 17:26:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/22 15:30:29 | ||
2 | Update | 2016/06/22 16:41:43 | Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2017/01/21 15:25:43 | Name of primary person or sponsor Organization |
|
4 | Update | 2017/07/01 17:26:16 | Recruitment status Publication of results |